Mesoblast (MESO) Equity Ratio (2015 - 2022)

Mesoblast has disclosed Equity Ratio across 8 years of filings, most recently posting 0.75 for Q2 2022.

• Equity Ratio for Q2 2022 came in at 0.75, down 3.85% year-over-year; the trailing twelve-month figure through Jun 2022 was 0.75 (down 3.85% YoY), and the FY2022 annual result was 0.75, down 3.85% from the prior year.
• Equity Ratio came in at 0.75 for Q2 2022 at Mesoblast, down from 0.78 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.79 in Q2 2018 to a low of 0.74 in Q2 2019.
• The 5-year median for Equity Ratio is 0.75 (2022), against an average of 0.76.
• Across the five-year window, Equity Ratio dropped 6.45% in 2019 and increased 4.26% in 2021, its largest moves.
• Mesoblast's Equity Ratio stood at 0.79 in 2018, then decreased by 6.45% to 0.74 in 2019, then grew by 1.51% to 0.75 in 2020, then climbed by 4.26% to 0.78 in 2021, then decreased by 3.85% to 0.75 in 2022.
• The last three Equity Ratio figures came in at 0.75 (Q2 2022), 0.78 (Q2 2021), and 0.75 (Q2 2020), per Business Quant data.